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Background: Uremic syndrome is a consequence of the retention of uremic solutes. Indoxyl sulfate (IS)
and para-cresol (p-cresol) belong to the group of protein-bound uremic toxins that are poorly cleared by
dialysis and are associated with poor clinical outcomes. The goal of our study was to evaluate the serum
levels of IS and p-cresol in elderly dialysis patients.
Methods: One hundred two stable hemodialysis patients from a single medical center were selected and
divided into elderly and nonelderly groups based on the age at which they started dialysis. The elderly
patients were also classiﬁed into diabetic and nondiabetic groups. The serum levels of total and free
p-cresol and IS were measured using ultra performance liquid chromatography. Biochemical data were
also collected concurrently.
Results: There were no statistical differences in biochemistry or in serum IS and p-cresol levels (total or
free) between the elderly and nonelderly groups. For the elderly dialysis patients, total IS was positively
related to age (r¼0.31, p< 0.01); calcium level (r¼ 0.297, p< 0.05); and creatinine (r¼ 0.44, p< 0.01).
Total p-cresol had a signiﬁcant relationship with diabetes (r¼ 0.30, p< 0.01). Neither total nor free
p-cresol was associated with any biochemical result. The elderly diabetic group had signiﬁcantly higher
serum total p-cresol level (p¼ 0.035) when compared with the nondiabetic group.
Conclusion: This study shows that the elderly hemodialysis patients do not have higher serum p-cresol
and IS levels. Diabetes was associated with serum total p-cresol level in elderly dialysis patients.
Copyright  2011, Taiwan Society of Geriatric Emergency & Critical Care Medicine. Published by Elsevier
Taiwan LLC. All rights reserved.1. Introduction
Chronic renal failure is characterized by the retention of mole-
cules that are normally cleared from the blood into the urine. These
molecules may deteriorate the biochemical and physiological
functions that deﬁne the uremic syndrome1. Protein-bound uremic
toxins, including at least 25 kinds of different toxins, have been
neglected for a long time, and their clinical importance has been
demonstrated in recent years. Indoxyl sulfate (IS) and para-cresol
(p-cresol) belong to protein-bound uremic toxins and accumulate
as renal function declines2.
Both of the toxins emanate from the metabolism of amino acids
by the intestinal ﬂora and are strongly protein bound3,4. p-cresolf Nephrology, Department of
ng San North Road, Section 2,
n).
erest.
lly to this article.
iwan Society of Geriatric Emergencauses various toxic effects in vitro, including inhibiting platelet-
activating factor synthesis5, decreasing the response of activated
polymorphonuclear leukocytes6, and reducing endothelial cell
response to inﬂammatory cytokines7. Total and/or free p-cresol
concentrations also have been reported to be associated with the
clinical condition in hemodialysis (HD) patients8e10. Recently,
evidence showed that greater free p-cresol levels correlated with
greater mortality11 and proposed that free p-cresol is a novel
cardiovascular risk factor in nondiabetic HD patients12.
Another protein-bound uremic toxin, IS, is associated with the
progression of chronic kidney disease13. Administration of IS in an
animal study has been reported to result in decreased renal function
and increased glomerular sclerosis14. In addition, endothelial
proliferation and wound repair were also inhibited by IS15. IS was
regarded to be involved in the pathogenesis of atherosclerosis in
dialysis patients16. These ﬁndings show the importance of IS in HD
patients. However, the population of elderly is increasing inces-
santly all over theworld, and the physiology of this group is different
from that of the general population. Until now, there is littlecy & Critical Care Medicine. Published by Elsevier Taiwan LLC. All rights reserved.
Table 1
Baseline patient demographics
Variable Patient demographics
HD patients (n¼ 102)
Median age (yr) 63.06 8.22
Men 59 (57.8)
Women 43 (42.2)
Time of HD (mo) 41.03 22.8
cGN 48 (47.1)
Diabetes 46 (45.1)
PKD 6 (5.9)
SLE 2 (1.9)
HTN 87 (87)
SBP (mmHg) 145.31 16.02
DBP (mmHg) 85.01 7.44
nPCR (g/kg/d) 1.21 0.13
rKt/V 0.07 0.12
Kt/V 1.66 0.15
Bicarbonate (mmol/L) 22.48 1.62
Hemoglobin (g/dL) 10.52 1.31
Creatinine (mg/dL) 11.02 2.21
Hct (%) 31.11 3.32
Albumin (g/dL) 4.03 0.25
Highly sensitive C-reactive protein (mg/dL) 0.74 0.59
Calcium (mg/dL) 8.93 0.61
Phosphate (mg/dL) 5.31 1.05
Alkaline phosphate (IU/L) 100.56 34.52
i-PTH (pg/mL) 333.21 191.83
Data are presented as n (%) or mean standard deviation.
cGN¼ chronic glomerulonephropathy; DBP¼ diastolic blood pressure; Hct¼
hematocrit; HD¼ hemodialysis; HTN¼ hypertension; i-PTH¼ intact-parathyroid
hormone; nPCR¼ normalized protein catabolic rate; PKD¼ polycystic kidney;
SBP¼ systolic blood pressure; SLE¼ systemic lupus erythematosus.
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elderly HD patients. Thus, our study objective was to evaluate the
serum levels of p-cresol and IS in elderly dialysis patients.
2. Materials and Methods
2.1. Patients
Our study comprised of 102 stable HD patients, aged 30e80
years, from a single medical center. Patients with advanced liver
cirrhosis, malignancy, acute infection, or less than 18 years of age
were excluded from this study. These patients were classiﬁed into
two groups based on their age at ﬁrst dialysis. Group 1 enrolled 52
patients who started HD at an age less than 65 years and Group 2
enrolled 50 patients who started HD at an age greater than or equal
to 65 years. The cause of end-stage renal failure in the total number
of patients was Type 2 diabetic nephropathy (n¼ 46), chronic
glomerulonephritis (n¼ 48), polycystic kidney disease (n¼ 6), or
lupus nephritis (n¼ 2). To analyze the effect of diabetes on serum IS
and p-cresol levels in elderly patients, 50 patients were also clas-
siﬁed into diabetic and nondiabetic groups.
All patients had been on 4-hour maintenance dialysis three
times a week for 6e100 months using a synthetic dialysis
membrane (polysulfone or polyamide). Dialyzers were not reused
for all patients. Dialysis efﬁciency was evaluated according to the
Kidney Disease Outcomes Quality Initiative guidelines, and single-
pool Kt/V of urea nitrogen was calculated17. Residual renal function
was estimated from an interdialytic urine collection and expressed
as weekly renal Kt/V (rKt/V). As a measure of daily protein intake,
normalized protein catabolic rate (g/kg/d) was calculated. The total
and free forms of p-cresol and IS were measured in each group.
Patient characteristics and biochemical parameters, including age,
gender, intact-parathyroid hormone, calcium, phosphate, highly
sensitive C-reactive protein (hs-CRP), and alkaline phosphate, were
examined concurrently.
The study was performed according to the Declaration of
Helsinki Principles and approved by the ethics committees of the
Mackay Memorial Hospital. Informed consent was obtained from
all patients.
2.2. Laboratory assessment
All blood samples were obtained just before dialysis procedure,
and the following analyses were performed: Hemoglobin (g/dL),
calcium (mg/dL), phosphate (mg/dL), bicarbonate (mmol/L), intact-
parathyroid hormone (pg/mL), albumin (g/dL), urea (mg/dL), creati-
nine (mg/dL), total IS (mg/L), free IS (mg/L), total p-cresol (mg/L), and
free p-cresol (mg/L). The bromocresol greenmethodwas used for the
determinationof albumin. The serumlevels ofhs-CRPweremeasured
using a Behring Nephelometer II (Dade Behring, Tokyo, Japan).
Serum p-cresol and IS (i.e., combined free and protein-bound
fractions) were analyzed with ultra performance liquid chroma-
tography (UPLC). In summary, serum samples were deproteinized
by the addition of three parts methanol to one part serum for
determination of IS. Total p-cresol (i.e., the combined free and
protein-bound fraction) was analyzed after deproteinization (acid
and heat) and extraction (ethyl acetate) of serum samples. The free
concentrations of IS and p-cresol were measured in serum ultra-
ﬁltrates obtained using Microcon YM-30 separators (Millipore,
Billerica, MA, USA), followed by the same sample preparation and
analysis that was done for serum p-cresol and IS. A UPLC assay
using detection at the 280-nm setting of the photodiode array
detector was performed at room temperature on an ACQUITY UPLC
BEH (Milford,MA, USA) phenyl column of 2.1100 mm. Buffer ﬂow
was 0.4 mL/min using 10mM NH4H2PO4 (pH¼ 4.0) (A) and 100%acetonitrile (B) with a gradient from 82.5%A/17.5%B to 55%A/45%B,
over 9 minutes.
Under these conditions, IS and p-cresol appeared at 1.4 minutes
and 2.75minutes, respectively. Standard curves from IS and p-cresol
at 0.5 mg/L, 1 mg/L, 2.5 mg/L, 5 mg/L, and 10 mg/L, processed in the
same manner as the serum samples, correlated with the serum
samples with average r2 values of 0.999 0.001. Quantitative results
were obtained and calculated as concentrations (mg/L). The sensi-
tivities of this assay were 0.225 mg/L for IS and 0.425 mg/L for
p-cresol. At the initiation of study, blood samples of patients were
taken immediately before the HD session two times a week (second
and third session). All serum p-cresol and IS were measured two
times a week to obtain an average value. Other biochemistries were
measured before the second HD session during the same week.
2.3. Statistical analysis
All continuous results were expressed as the mean standard
deviation. The results from the elderly and nonelderly groups were
compared using Student t tests. The diabetic effect on elderly
dialysis patients was also analyzed by Student t tests. A value of p
less than 0.05 was considered statistically signiﬁcant. In our search
for relationships among variables, Pearson’s correlation test was
used. All statistical analyses were conducted using SigmaStat for
Windows, version 2.03 (SPSS Inc., Chicago, IL, USA).
3. Results
Total patient demographics are shown in Table 1. Of the 102
study participants (mean age, 63.06 8.22 years; 59 males and 43
females), 87 (87%) had hypertension, 46 (45.1%) had diabetes, 48
(47.1%) had chronic glomerulonephropathy, 6 (5.9%) had polycystic
kidney disease, and 2 (1.9%) had lupus nephritis. Mean systolic
blood pressure and diastolic pressure were 145.3116.02 mmHg
and 85.017.44 mmHg, respectively.
Table 2
Clinical characteristics of HD patients stratiﬁed by age of starting dialysis
Variables Age (yr) p
65 (n¼ 52) <65 (n¼ 50)
Mean SD Mean SD
Time to HD (mo) 38.55 25.87 42.27 31.98 NS
SBP (mmHg) 143.80 20.80 150.49 19.85 NS
DBP (mmHg) 84.31 12.84 84.61 6.94 NS
rKt/V 0.05 0.08 0.11 0.19 NS
Kt/V 1.68 0.31 1.65 0.31 NS
Albumin (mg/dL) 4.05 0.34 4.06 0.33 NS
nPCR (g/kg/d) 1.21 0.13 1.20 0.15 NS
Bicarbonate (mmol/L) 22.64 1.94 21.87 2.43 NS
Hemoglogin (g/dL) 10.24 1.58 10.65 1.55 NS
Hct (%) 30.15 4.79 31.65 4.57 NS
Calcium (mg/dL) 8.82 0.66 8.97 0.78 NS
Phosphate (mg/dL) 5.02 1.22 5.44 1.33 NS
i-PTH (pg/mL) 291.44 235.09 377.88 272.54 NS
Alkaline phosphate (IU/L) 94.27 32.95 109.18 60.40 NS
Creatinine (mg/dL) 10.36 2.32 11.39 2.75 0.046
Highly sensitive C-reactive
protein (mg/dL)
0.97 1.75 0.51 0.69 0.090
Total IS (mg/L) 40.54 16.73 40.66 17.23 NS
Total PC (mg/L) 21.99 12.08 21.17 13.99 NS
Free IS (mg/L) 4.27 2.90 4.69 3.20 NS
Free PC (mg/L) 1.59 1.12 1.57 1.40 NS
DBP¼ diastolic blood pressure; Hct¼ hematocrit; HD¼ hemodialysis; i-PTH¼
intact-parathyroid hormone; IS¼ indoxyl sulfate; nPCR¼ normalized protein cata-
bolic rate; NS¼ no signiﬁcance; PC¼ p-cresol; SBP¼ systolic blood pressure;
SD¼ standard deviation.
Table 4
The relationship of general biochemistry, IS, and PC between diabetic and nondia-
betic groups in elderly dialysis patients
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uremic toxins for the elderly group (65 years old) compared
with the nonelderly group (<65 years old). There was no statistical
difference in biochemistry and in serum IS and p-cresol levels (total
and free) between the two groups except for creatinine (p¼ 0.046).
The relationships between p-cresol and IS levels and the
biochemical parameters for the elderly groups were analyzed by
Pearson’s correlation test, and the results are shown in Table 3.
Total IS was negatively related to age (r¼0.31, p< 0.01); calcium
level (r¼ 0.297, p< 0.05); and creatinine (r¼ 0.44, p< 0.01). Free IS
was related to creatinine (r¼ 0.37, p< 0.01). The total p-cresol had
a signiﬁcant relationship with diabetes (r¼ 0.30, p< 0.01). Neither
total nor free p-cresol was associated with any biochemical result.Table 3
The correlation between PC and IS and biochemical parameters for elderly group
analyzed by Pearson’s correlation
Variables Total IS
(mg/L)
Total PC
(mg/L)
Free IS
(mg/L)
Free PC
(mg/L)
DM 0.13 0.30* 0.13 0.10
Age 0.31* 0.06 0.23 0.11
Time to hemodialysis (mo) 0.23 0.06 0.19 0.16
SBP 0.01 0.14 0.04 0.06
DBP 0.10 0.07 0.08 0.14
rKt/V 0.22 0.02 0.15 0.07
Kt/V 0.24 0.27 0.12 0.04
Albumin 0.23 0.17 0.09 0.09
nPCR 0.23 0.13 0.04 0.03
Bicarbonate 0.13 0.25 0.10 0.19
Hemoglobin 0.12 0.03 0.09 0.01
Hct 0.13 0.02 0.11 0.01
Calcium 0.30* 0.07 0.23 0.07
Phosphate 0.20 0.10 0.23 0.05
i-PTH 0.04 0.10 0.04 0.03
Alkaline phosphate 0.09 0.16 0.10 0.10
Creatinine 0.44** 0.05 0.37** 0.04
DBP¼ diastolic blood pressure; DM¼ diabetes mellitus; Hct¼ hematocrit;
i-PTH¼ intact-parathyroid hormone; IS¼ indoxyl sulfate; nPCR¼ normalized
protein catabolic rate; PC¼ p-cresol; SBP¼ systolic blood pressure.
* p< 0.05
** p< 0.01.To analyze the effect of diabetes on serum IS and p-cresol levels,
the 52 elderly dialysis patients were divided into diabetic and
nondiabetic groups. Table 4 shows the relationship of general
biochemistry and IS and p-cresol levels between the diabetic and
nondiabetic groups. The diabetic group had a signiﬁcantly higher
serum total p-cresol level (p¼ 0.035) compared with the nondia-
betic group. Other biochemical results did not show a signiﬁcant
difference between the two groups.4. Discussion
In this study, we found that the level of serum protein-bound
uremic toxinsdtotal and free p-cresol and ISdwas no different
between the elderly and nonelderly dialysis patients. Diabetes
seems to be an independent factor that affects serum total p-cresol
rather than IS in elderly.
Uremic toxins accumulate and lead to uremic syndrome as
glomerular ﬁltration rate declines. Earlier studies, including the
Hemodialysistrial18 and the Adequacy of Dialysis Mexico trial19,
showed that increasing the removal of water-soluble solutes did
not reduce mortality in dialysis patients. This ﬁnding indicates that
uremic solutes other than small water-soluble molecules may play
a role in patient outcomes. Consequently, the focus of the
nephrology community is shifting toward protein-bound uremic
toxins. P-cresol and IS are representative molecules of this group2.
Both molecules are produced by the intestinal ﬂora as a metabolite
of aromatic amino acids and metabolized by the liver. P-cresol and
IS are not removed efﬁciently by standard dialysis techniques
because of their high protein-binding ability, and they have been
shown to have deleterious effects on the endothelium in vitro
study7,20.
In serum,more than 90% of p-cresolwas present in the formof its
conjugate, p-cresylsulfate21. This conjugate may potentially lead to
proinﬂammatory effect on leukocytes22. However, serum free
p-cresol level was measured in some studies, and the toxicity of
serum free p-cresol was also demonstrated in vitro and in vivo. The
causeof thedifferencebetweenp-cresylsulfateand freep-cresolwasVariables Elderly HD patients p
DM (n¼ 24) Non-DM (n¼ 28)
Mean SD Mean SD
Time to hemodialysis (mo) 31.95 24.31 43.93 26.30 NS
SBP (mmHg) 144.64 22.56 143.11 19.67 NS
DBP (mmHg) 83.36 14.86 85.07 11.17 NS
rKt/V 0.05 0.05 0.04 0.10 NS
Kt/V 1.60 0.27 1.75 0.32 NS
Albumin (mg/dL) 4.00 0.31 4.10 0.37 NS
nPCR (g/kg/d) 1.19 0.12 1.22 0.14 NS
Bicarbonate (mmol/L) 22.98 1.76 22.37 2.06 NS
Hemoglobin (g/dL) 10.15 1.47 10.33 1.70 NS
Hct (%) 29.90 4.68 30.35 4.95 NS
Calcium (mg/dL) 8.67 0.70 8.95 0.60 NS
Phosphate (mg/dL) 4.89 1.24 5.13 1.23 NS
i-PTH (pg/mL) 228.97 155.64 342.34 276.53 NS
Alkaline phosphate (IU/L) 95.82 35.23 93.00 31.59 NS
Creatinine (mg/dL) 9.83 2.03 10.80 2.48 NS
Highly sensitive C-reactive
protein (mg/dL)
1.32 2.36 0.68 0.98 NS
Total IS (mg/L) 38.15 13.07 42.49 19.24 NS
Total PC (mg/L) 26.00 11.86 18.73 11.45 0.035
Free IS (mg/L) 3.88 2.79 4.60 3.00 NS
Free PC (mg/L) 1.71 1.18 1.49 1.08 NS
DBP¼ diastolic blood pressure; DM¼ diabetes mellitus; Hct¼ hematocrit; i-PTH¼
intact-parathyroid hormone; IS¼ indoxy sulfate; nPCR¼ normalized protein cata-
bolic rate; NS¼ no signiﬁcance; PC¼ p-cresol; SBP¼ systolic blood pressure.
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showed that the level of free p-cresol was associated with overall
mortality in dialysis patients after a 34-month follow-up. More
recently, Meijers et al12 regarded free p-cresol as a novel cardio-
vascular risk factor in nondiabetic HD patients. Our previous study
also suggested that serum free p-cresol and hs-CRP can predict
hospitalization because of infection for HD patients23. In this study,
p-cresol, including conjugated metabolites, was measured.
Another protein-bound uremic toxin, IS, was thought to play
a signiﬁcant role in the progression of chronic kidney disease13,
tubulointerstitial ﬁbrosis, and glomerular sclerosis by increasing
the gene expression of transforming growth factor-beta 1, tissue
inhibitor of metalloproteinase-1, and pro-alpha l (I) collagen24,25. In
addition, IS contributes to aortic wall thickening and aortic calci-
ﬁcation, along with expression of osteoblast-speciﬁc proteins in
hypertensive rats26. Taki et al16 reported that IS was linked to
atherosclerosis in dialysis patients.
Until this investigation, little data on IS and p-cresol in the elderly
had been available. Do the elderly dialysis patients have higher
serum level of p-cresol and IS than nonelderly patients? Based onour
results, the adequacy of all patients reached the targets recom-
mended by the Kidney Disease Outcomes Quality Initiative guide-
lines, and the general biochemical results were not different in the
elderly and nonelderly groups. However, we also found no signiﬁ-
cant difference in p-cresol and IS levels between the two groups. As
we know, the factor that affects the serum concentration of p-cresol
and IS is multifactorial in origin. Both p-cresol and IS are produced
and absorbed from the intestinal tract and are protein-bound uremic
toxins with high afﬁnity to serum protein. It could not be removed
effectively by dialysis in both the elderly and the nonelderly groups.
In general, gastrointestinal function of absorption in elderly is infe-
rior to that in the general population. Whether the elderly patients
had less p-cresol and IS absorption than nonelderly is unknown.
However, therewere no differences of serum levels of IS and p-cresol
in young and elder populations based on our results.
In addition, residual renal function was an important factor that
affected the serum level of p-cresol and IS in dialysis patients, but it
showed no difference in both groups. Infectionwas also regarded as
a factor leading to higher serum p-cresol level in dialysis9. The hs-
CRP level was not signiﬁcantly different between the elderly and
the nonelderly groups. It indicated that infection is not the possible
cause to affect serum p-cresol and IS level in this study.
As to the question of whether diabetes is an independent factor
in elderly when it comes to serum IS and p-cresol levels, our results
indicate that there was a signiﬁcant difference in the total p-cresol
levels between the elderly patients with diabetes and the elderly
patients without diabetes. In one cohort study for general pop-
ulation, Meijers et al12 reported that the diabetic group had higher
concentrations of both free p-cresol and total p-cresol than the
nondiabetic group. This point is consistent with our result.
However, the authors indicated that a possible cause for this ﬁnding
was that diabetic patients have an increased risk for developing
malnutrition but it could not be observed in our study. The possible
reason for the controversy is different study population, and it
seems that there are other factors affecting their serum concen-
tration. Another question is whywould diabetes only affect p-cresol
rather than IS? A precise reason for this is unclear. Interestingly,
based on our results, it showed a trend that patients with diabetes
had lower serum IS level than those without diabetes (38.15 vs.
42.49), although the p value did not have a signiﬁcant difference.
Perhaps, the effect of diabetes on IS was attenuated by other factors
in elderly. Another possibility is that the serum level of p-cresol and
IS are also inﬂuenced by dietary habits27. Whether this is related to
particular dietary habits is not clear. Further study is required to
conﬁrm this observation.5. Conclusion
Our results showed that there was no difference in the serum
levels of IS and p-cresol between elderly and nonelderly dialysis
patients. Elderly dialysis patients with diabetes had higher serum
total p-cresol levels than the nondiabetic ones.
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